The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Will The Market Value Of The Metered Dose Inhaler Devices Market Increase Between 2026 And 2030?
The metered dose inhaler devices market size has experienced significant growth in recent years. It is projected to increase from $16.23 billion in 2025 to $17.12 billion in 2026, at a compound annual growth rate (CAGR) of 5.5%. The expansion observed in the historic period can be attributed to factors such as the rising prevalence of asthma, increasing incidence of COPD, widespread adoption of inhalation therapy, physician preference for mdIs, and the availability of generic inhalers.
The metered dose inhaler devices market is projected for substantial expansion in the coming years. This market is anticipated to reach $21.06 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.3%. This expansion over the forecast period is attributable to several factors, including the increasing adoption of smart inhalers, stringent environmental regulations concerning propellants, the growth of homecare treatment options, rising demand for digital adherence monitoring, and the development of new respiratory therapies. Key trends expected during this period encompass smart dose tracking inhaler systems, advancements in breath-actuated inhalation technology, the introduction of compact and portable device designs, improvements in dose accuracy, and the wider adoption of eco-friendly propellants.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20878&type=smp
What Important Drivers Are Powering The Metered Dose Inhaler Devices Market Growth?
The expansion of the metered dose inhaler devices market is anticipated due to the growing occurrence of chronic obstructive pulmonary diseases. Chronic obstructive pulmonary disease (COPD) is a progressive respiratory condition marked by restricted airflow, frequently resulting from prolonged exposure to irritants like cigarette smoke, which manifests as breathlessness, coughing, and wheezing. The increasing incidence of COPD is influenced by factors such as tobacco consumption, environmental pollution, an aging global demographic, and insufficient or late detection and treatment. Metered dose inhaler (MDI) devices are crucial in managing COPD by delivering medication directly into the lungs, thus offering rapid symptom alleviation and enhancing respiratory function. For instance, in December 2023, the National Institutes of Health, a US-based government agency, forecasted that the number of COPD cases would increase from 532 million in 2030 to a total of 592 million by 2050. Consequently, the rising prevalence of chronic obstructive pulmonary diseases is a significant factor driving the growth of the metered dose inhaler devices market.
What Are The Core Segment Classifications In The Metered Dose Inhaler Devices Market?
The metered dose inhaler devices market covered in this report is segmented –
1) By Type: Desktop Metered Dose Inhaler Devices, Portable Metered Dose Inhaler Devices, Other Types
2) By Distribution Channel: Online, Offline
3) By Application: Asthma, Chronic Obstructive Pulmonary Disease, Other Applications
4) By End-User: Hospitals, Clinics, Homecare Settings, Other End Users
Subsegments:
1) By Desktop Metered Dose Inhaler Devices: Standard desktop MDI devices, High-performance desktop MDI devices, Smart desktop MDI devices
2) By Portable Metered Dose Inhaler Devices: Conventional portable MDI devices, Advanced portable MDI devices, Smart portable MDI devices
3) By Other Types: Nebulizer-Based MDI devices, Dry powder inhaler (DPI) combined devices, Soft mist inhaler (SMI) devices, Other specialized MDI devices
Which Trends Are Influencing The Expansion Of The Metered Dose Inhaler Devices Market?
Leading companies in the metered dose inhaler devices market are concentrating on developing technologically advanced solutions, including pressurized metered dose inhalers, to enhance drug delivery efficiency and improve patient adherence. Pressurized metered-dose inhalers (pMDIs) are inhalation devices that deliver an exact amount of medication in aerosol form through a pressurized propellant. For example, in July 2023, Lupin Limited, an India-based pharmaceutical company, introduced Luforbec 100/6, a pressurized metered dose inhaler (pMDI) for managing adult asthma and chronic obstructive pulmonary disease (COPD) in Germany. This product integrates beclometasone (100 µg) and formoterol (6 µg), offering an effective option for patients requiring combination therapy. Significantly, Luforbec is priced approximately 47% lower than the fixed reference price, thereby improving its accessibility. Considering that asthma affects about 5% of adults in Germany, this launch highlights Lupin’s commitment to addressing critical healthcare needs and enhancing patient outcomes in respiratory care.
Which Firms Are Competing In The Metered Dose Inhaler Devices Market?
Major companies operating in the metered dose inhaler devices market are Pfizer Inc., Merck & Co. Inc., AstraZeneca PLC, GlaxoSmithKline plc, 3M Company, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Berry Global Inc., AptarGroup Inc., Philips Healthcare, Chiesi Farmaceutici S.p.A., Cipla Limited, Gerresheimer AG, Zydus Lifesciences Limited, Mylan N.V., Nemera, Beximco Pharmaceuticals Limited, Cohero Health Inc., Bespak Europe Ltd., Trudell Medical International, Iconovo AB
Access The Complete Metered Dose Inhaler Devices Market Report:
https://www.thebusinessresearchcompany.com/report/metered-dose-inhaler-devices-global-market-report
Which Geographic Region Represents The Largest Metered Dose Inhaler Devices Market Share?
North America was the largest region in the metered dose inhaler devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metered dose inhaler devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Metered Dose Inhaler Devices Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/report/metered-dose-inhaler-devices-global-market-report
Browse Through More Reports Similar to the Global Metered Dose Inhaler Devices Market 2026, By The Business Research Company
Respiratory Inhaler Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/respiratory-inhaler-devices-global-market-report
Smart Inhalers Market Report 2026
https://www.thebusinessresearchcompany.com/report/smart-inhalers-global-market-report
Albuterol Market Report 2026
https://www.thebusinessresearchcompany.com/report/albuterol-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model